Alimera Technical Analysis

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;padding-top: 25px;;'>AS</div>
ALIM -- USA Stock  

Fiscal Quarter End: 30th of June 2020  

As of the 2nd of June Alimera Sciences shows Risk Adjusted Performance of 0.0576, Downside Deviation of 8.2 and Mean Deviation of 6.09. Alimera Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Alimera Sciences, which can be compared to its rivals. Please confirm Alimera Sciences Variance as well as the relationship between Maximum Drawdown and Semi Variance to decide if Alimera Sciences is priced correctly providing market reflects its regular price of 5.03 per share. Given that Alimera Sciences has Jensen Alpha of 0.1218, we suggest you validate Alimera Sciences prevailing market performance to make sure the company can sustain itself at future point.

Search Technical Analysis

Target PriceAdvice# of Analysts
14.5Strong Buy2Odds
Alimera Sciences current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Alimera Sciences Analyst Advice  
Alimera Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Alimera Sciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst, therefore, looks at the history of Alimera Sciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Alimera Sciences Technical Analysis

The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of Alimera Sciences volatility developed by Welles Wilder. View also all equity analysis or get more info about true range volatility indicators indicator.

Alimera Sciences Trend Analysis

Use this graph to draw trend lines for Alimera Sciences. You can use it to identify possible trend reversals for Alimera Sciences as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Alimera Sciences price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Alimera Sciences Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Alimera Sciences applied against its price change over selected period. The best fit line has a slop of   0.020695  which means Alimera Sciences will continue generating value for investors. It has 122 observation points and a regression sum of squares at 16.2, which is the sum of squared deviations for the predicted Alimera Sciences price change compared to its average price change.

About Alimera Sciences Technical Analysis

The Macroaxis Technical Analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Alimera Sciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Alimera Sciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Alimera Sciences stock first instead of the macroeconomic environment surrounding Alimera Sciences. By analyzing Alimera Sciences's financials, daily price indicators, and its related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Alimera Sciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Alimera Sciences specific price patterns or momentum indicators. Please read more on our technical analysis page.

Alimera Sciences June 2, 2020 Technical Indicators

Alimera Sciences June 2, 2020 Daily Price Condition

 2017 2018 2019 2020 (projected)
PPandE Turnover22.4733.9747.0150.72
Long Term Debt to Equity2.3214.0312.6213.62
Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. Alimera Sciences, Inc. was founded in 2003 and is headquartered in Alpharetta, Georgia. Alimera Sciences operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 122 people.
Please continue to Trending Equities. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page